WASHINGTON, Aug 16 (Reuters) - Acologix Inc., a biopharmaceutical company, filed with the U.S. Securities and Exchange Commission on Wednesday to raise up to $115 million in an initial public offering of stock.
WASHINGTON, Aug 16 (Reuters) - Acologix Inc., a biopharmaceutical company, filed with the U.S. Securities and Exchange Commission on Wednesday to raise up to $115 million in an initial public offering of stock.
